A High‐Throughput RP‐UPLC Assay for Simultaneous Determination of Telmisartan and Azelnidipine in Pharmaceutical Formulations
Biotechnology and Applied Biochemistry · 2025-12 · 72 (6) · 1595-1604
DOI: 10.1002/bab.2765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 04.05.2025. Verfasst von BhargavaKrishna Pogaku und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Sciences, University College of Engineering, Science & Technology, Jawaharlal Nehru Technological University, Hyderabad, In…. Hauptthemen laut MEDLINE: Chromatography, High Pressure Liquid, Telmisartan, Azetidinecarboxylic Acid, Dihydropyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Telmisartan, an angiotensin II receptor blocker, and azelnidipine, a dihydropyridine calcium channel blocker, are often co‐prescribed for the effective management of hypertension. The development of accurate and efficient analytical methods is crucial for ensuring the quality control of these combination formulations. This study presents a rapid and reliable reversed‐phase ultra‐performance liquid chromatography (RP‐UPLC) assay for the simultaneous determination of telmisartan and azelnidipine in pharmaceutical formulations. Efficient chromatographic separation was achieved on an ACQUITY BEH C18 column (100 mm × 2.1 mm, 3 µm) using an isocratic mobile phase of pH 4.0 ammonium acetate buffer and acetonitrile (75:25% v/v) at a flow rate of 0.5 mL/min. Detection was performed at 260 nm, with telmisartan and azelnidipine eluting at 1.833 and 3.583 min, respectively. The method demonstrated good efficiency and minimal tailing ( 0.999) over a concentration range of 50–150%. Recoveries from tablet dosage forms ranged from 98.0% to 102.0%, with assay values falling within the prescribed range. This validated that reversed‐phase ultra‐performance liquid chromatography assay offers a high‐throughput approach suitable for routine quality control analysis of telmisartan and azelnidipine in pharmaceutical formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pharmaceutical Sciences, University College of Engineering, Science & Technology, Jawaharlal Nehru Technological University, Hyderabad, India.
- Centre for Pharmaceutical Sciences, Institute of Science and Technology, Jawaharlal Nehru Technological University, Hyderabad, India.
- SIMATS Engineering, SIMATS University, Chennai, India.
- Panimalar Engineering College, Chennai, India.
- R.M.K Engineering College, Kavaraipettai, Tiruvallur District, India.
ORCID-Profile: Rama Krishna Reddy Guduru
Zitieren
APA
Pogaku, B., Makula, A., G, M., Santhosh, S., Gnanasambanthan, H., Sarkar, S., & Guduru, R. K. R. (2025). A High‐Throughput RP‐UPLC Assay for Simultaneous Determination of Telmisartan and Azelnidipine in Pharmaceutical Formulations. Biotechnology and Applied Biochemistry, 72(6), 1595-1604. https://doi.org/10.1002/bab.2765
Vancouver
Pogaku B, Makula A, G M, Santhosh S, Gnanasambanthan H, Sarkar S, et al. A High‐Throughput RP‐UPLC Assay for Simultaneous Determination of Telmisartan and Azelnidipine in Pharmaceutical Formulations. Biotechnology and Applied Biochemistry. 2025;72(6):1595-1604. doi:10.1002/bab.2765
BibTeX
@article{Pogaku2025,
author = {Pogaku, BhargavaKrishna and Makula, Ajitha and G, Mohandass and Santhosh, Sheeba and Gnanasambanthan, Harish and Sarkar, Sambit and Guduru, Rama Krishna Reddy},
title = {A High‐Throughput RP‐UPLC Assay for Simultaneous Determination of Telmisartan and Azelnidipine in Pharmaceutical Formulations},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
volume = {72},
number = {6},
pages = {1595--1604},
doi = {10.1002/bab.2765}
}
EUVIMED